Inflammation in Atherosclerosis: From Vascular Biology to Biomarker Discovery and Risk Prediction

Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944

Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)

Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011

Inflammation and metabolic disorders

Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199

Inflammation, Atherosclerosis, and Coronary Artery Disease

Hansson, G. K. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043430 · Cited by 8,773

Inflammation in atherosclerosis

Libby, P. (2002) · Nature · doi:10.1038/nature01323 · Cited by 8,315

Inflammation and Atherosclerosis

Libby, P., Ridker, P. M., & Maseri, A. (2002) · Circulation · doi:10.1161/hc0902.104353 · Cited by 7,724

Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: A Statement for Healthcare Professionals From the Centers for Disease Control and Prevention and the American Heart Association

Pearson, T. A., Mensah, G. A., Alexander, R. W., Anderson, J. L., Cannon, R. O., Criqui, M., Fadl, Y. Y., Fortmann, S. P., Hong, Y., Myers, G. L., et al. (2003) · Circulation · doi:10.1161/01.cir.0000052939.59093.45 · Cited by 6,401

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

Ridker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421202 · Cited by 5,850

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504

Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events

Ridker, P. M., Rifai, N., Rose, L., Buring, J. E., & Cook, N. R. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021993 · Cited by 3,604

Atherosclerosis

Glass, C. K., & Witztum, J. L. (2001) · Cell · doi:10.1016/s0092-8674(01)00238-0 · Cited by 3,094

C-Reactive Protein and Other Circulating Markers of Inflammation in the Prediction of Coronary Heart Disease

Danesh, J., Wheeler, J. G., Hirschfield, G. M., Eda, S., Eiriksdottir, G., Rumley, A., Lowe, G. D. O., Pepys, M. B., & Gudnason, V. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032804 · Cited by 2,953

Mechanisms linking obesity with cardiovascular disease

Van Gaal, L. F., Mertens, I. L., & De Block, C. E. (2006) · Nature · doi:10.1038/nature05487 · Cited by 2,814

From Vulnerable Plaque to Vulnerable Patient

Naghavi, M., Libby, P., Falk, E., Casscells, S. W., Litovsky, S. H., Rumberger, J. A., Badimón, J. J., Stefanadis, C., Moreno, P., Pasterkamp, G., et al. (2003) · Circulation · doi:10.1161/01.cir.0000087481.55887.c9 · Cited by 2,679

Cloning of a new cytokine that induces IFN-γ production by T cells

Okamura, H., Tsutsui, H., Komatsu, T., Yutsudo, M., Hakura, A., Tanimoto, T., Torigoe, K., Okura, T., Nukada, Y., Hattori, K., et al. (1995) · Nature · doi:10.1038/378088a0 · Cited by 2,602

Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques.

Galis, Z. S., Sukhova, G. K., Lark, M. W., & Libby, P. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117619 · Cited by 2,537

The many roles of chemokines and chemokine receptors in inflammation

Charo, I. F., & Ransohoff, R. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052723 · Cited by 2,523

Clinical application of C-reactive protein for cardiovascular disease detection and prevention

Ridker, P. M. (2003) · Circulation · doi:10.1161/01.cir.0000053730.47739.3c · Cited by 2,513

From Vulnerable Plaque to Vulnerable Patient

Naghavi, M., Libby, P., Falk, E., Casscells, S. W., Litovsky, S. H., Rumberger, J. A., Badimón, J. J., Stefanadis, C., Moreno, P., Pasterkamp, G., et al. (2003) · Circulation · doi:10.1161/01.cir.0000087480.94275.97 · Cited by 2,298

C-Reactive Protein Levels and Outcomes after Statin Therapy

Ridker, P. M., Cannon, C. P., Morrow, D., Rifai, N., Rose, L. M., McCabe, C. H., Pfeffer, M. A., & Braunwald, E. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042378 · Cited by 2,292

C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events: An 8-Year Follow-Up of 14 719 Initially Healthy American Women

Ridker, P. M., Buring, J. E., Cook, N. R., & Rifai, N. (2003) · Circulation · doi:10.1161/01.cir.0000055014.62083.05 · Cited by 2,292

The immune response in atherosclerosis: a double-edged sword

Hansson, G. K., & Libby, P. (2006) · Nature reviews. Immunology · doi:10.1038/nri1882 · Cited by 2,220

Decreased lesion formation in CCR2−/− mice reveals a role for chemokines in the initiation of atherosclerosis

Boring, L., Gosling, J., Cleary, M., & Charo, I. F. (1998) · Nature · doi:10.1038/29788 · Cited by 1,965

Pathophysiology of coronary artery disease

Libby, P., & Theroux, P. (2005) · Circulation · doi:10.1161/circulationaha.105.537878 · Cited by 1,965

Direct Proinflammatory Effect of C-Reactive Protein on Human Endothelial Cells

Pasceri, V., Willerson, J. T., & Yeh, E. T. H. (2000) · Circulation · doi:10.1161/01.cir.102.18.2165 · Cited by 1,944

Development and Validation of Improved Algorithms for the Assessment of Global Cardiovascular Risk in Women: The Reynolds Risk Score

Ridker, P. M., Buring, J. E., Rifai, N., & Cook, N. R. (2007) · JAMA · doi:10.1001/jama.297.6.611 · Cited by 1,814

Plasma Adiponectin Levels and Risk of Myocardial Infarction in Men

Pischon, T. (2004) · JAMA · doi:10.1001/jama.291.14.1730 · Cited by 1,782

Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways

Tedgui, A., & Mallat, Z. (2006) · Physiological Reviews · doi:10.1152/physrev.00024.2005 · Cited by 1,751

Endothelial Expression of a Mononuclear Leukocyte Adhesion Molecule During Atherogenesis

Cybulsky, M. I., & Gimbrone, M. A. (1991) · Science · doi:10.1126/science.1990440 · Cited by 1,710

Fibrinogen as a Risk Factor for Stroke and Myocardial Infarction

Wilhelmsen, L., Svärdsudd, K., Korsan-Bengtsen, K., Larsson, B., Welin, L., & Tibblin, G. (1984) · New England Journal of Medicine · doi:10.1056/nejm198408233110804 · Cited by 1,645

Current Concepts of the Pathogenesis of the Acute Coronary Syndromes

Libby, P. (2001) · Circulation · doi:10.1161/01.cir.104.3.365 · Cited by 1,575

Absence of Monocyte Chemoattractant Protein-1 Reduces Atherosclerosis in Low Density Lipoprotein Receptor–Deficient Mice

Gu, L., Okada, Y., Clinton, S. K., Gerard, C. J., Sukhova, G. K., Libby, P., & Rollins, B. J. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80139-2 · Cited by 1,574

Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events

Ridker, P. M., Rifai, N., Clearfield, M., Downs, J. R., Weis, S. E., Miles, J. S., & Gotto, A. M. (2001) · New England Journal of Medicine · doi:10.1056/nejm200106283442601 · Cited by 1,557

Effect of Weight Loss and Lifestyle Changes on Vascular Inflammatory Markers in Obese Women: A Randomized Trial

Esposito, K., Pontillo, A., Di Palo, C., Giugliano, G., Masella, M., Marfella, R., & Giugliano, D. (2003) · JAMA · doi:10.1001/jama.289.14.1799 · Cited by 1,511

Long-Term Effects of Pravastatin on Plasma Concentration of C-reactive Protein

Ridker, P. M., Rifai, N., Pfeffer, M. A., Sacks, F. M., & Braunwald, E. (1999) · Circulation · doi:10.1161/01.cir.100.3.230 · Cited by 1,471

Fibrinogen and risk of cardiovascular disease. The Framingham Study

Kannel, W. B. (1987) · JAMA · doi:10.1001/jama.258.9.1183 · Cited by 1,387

Role of cholesterol and lipid organization in disease

Maxfield, F. R., & Tabas, I. A. (2005) · Nature · doi:10.1038/nature04399 · Cited by 1,331

The pathogenesis of atherosclerosis

(1972) · American Heart Journal · doi:10.1016/0002-8703(72)90090-7 · Cited by 1,329

Statin Therapy, LDL Cholesterol, C-Reactive Protein, and Coronary Artery Disease

Nissen, S. E., Tuzcu, E. M., Schoenhagen, P., Crowe, T., Sasiela, W. J., Tsai, J., Orazem, J., Magorien, R. D., O'Shaughnessy, C., & Ganz, P. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042000 · Cited by 1,325

Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques

Tacke, F., Alvarez, D., Kaplan, T. J., Jakubzick, C., Spanbroek, R., Llodra, J., Garin, A., Liu, J., Mack, M., van Rooijen, N., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci28549 · Cited by 1,323

Immune cell migration in inflammation: present and future therapeutic targets

Luster, A. D., Alon, R., & von Andrian, U. H. (2005) · Nature Immunology · doi:10.1038/ni1275 · Cited by 1,313

Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata

Świrski, F. K., Libby, P., Aïkawa, E., Alcaide, P., Luscinskas, F. W., Weissleder, R., & Pittet, M. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29950 · Cited by 1,308

Novel Risk Factors for Systemic Atherosclerosis

Ridker, P. M., Stampfer, M. J., & Rifai, N. (2001) · JAMA · doi:10.1001/jama.285.19.2481 · Cited by 1,290

A major role for VCAM-1, but not ICAM-1, in early atherosclerosis

Cybulsky, M. I., Iiyama, K., Li, H., Zhu, S.-N., Chen, M., Iiyama, M., Davis, V., Gutierrez-Ramos, J.-C., Connelly, P. W., & Milstone, D. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11871 · Cited by 1,244

Inflammatory Markers and the Risk of Coronary Heart Disease in Men and Women

Pai, J. K., Pischon, T., Ma, J., Manson, J. E., Hankinson, S. E., JOSHIPURA, K. J., Curhan, G. C., Rifai, N., Cannuscio, C. C., Stampfer, M. J., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040967 · Cited by 1,186

Inflammation and cardiovascular disease mechanisms

Libby, P. (2006) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.2.456s · Cited by 1,114

Relation of C-Reactive Protein and Coronary Heart Disease in the MRFIT Nested Case-Control Study

Kuller, L. H., Tracy, R. P., Shaten, J., & Meilahn, E. N. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008963 · Cited by 1,098

Major Risk Factors as Antecedents of Fatal and Nonfatal Coronary Heart Disease Events

Greenland, P. (2003) · JAMA · doi:10.1001/jama.290.7.891 · Cited by 1,053

Subendothelial retention of atherogenic lipoproteins in early atherosclerosis

Skålén, K., Gustafsson, M., Rydberg, E. K., Hultén, L. M., Wiklund, O., Innerarity, T. L., & Borén, J. (2002) · Nature · doi:10.1038/nature00804 · Cited by 1,019

T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein.

Stemme, S., Faber, B., Holm, J., Wiklund, O., Witztum, J. L., & Hansson, G. K. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.9.3893 · Cited by 943

Reduction of atherosclerosis in mice by inhibition of CD40 signalling

Mach, F., Schönbeck, U., Sukhova, G. K., Atkinson, E., & Libby, P. (1998) · Nature · doi:10.1038/28204 · Cited by 910

Fibrinogen and Risk of Cardiovascular Disease

Kannel, W. B. (1987) · JAMA · doi:10.1001/jama.1987.03400090067035 · Cited by 894

C-Reactive Protein–Mediated Low Density Lipoprotein Uptake by Macrophages

Zwaka, T. P., Hombach, V., & Torzewski, J. (2001) · Circulation · doi:10.1161/01.cir.103.9.1194 · Cited by 848

Soluble CD40 Ligand in Acute Coronary Syndromes

Heeschen, C., Dimmeler, S., Hamm, C. W., van den Brand, M. J., Boersma, E. H., Zeiher, A. M., & Simoons, M. L. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022600 · Cited by 827

Plasminogen-Activator Inhibitor Type 1 and Coronary Artery Disease

Kohler, H. P., & Grant, P. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006153422406 · Cited by 805

Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins

Rajavashisth, T. B., Andalibi, A., Territo, M., Berliner, J. A., Navab, M., Fogelman, A. M., & Lusis, A. J. (1990) · Nature · doi:10.1038/344254a0 · Cited by 775

Adiponectin, Metabolic Risk Factors, and Cardiovascular Events among Patients with End-Stage Renal Disease

Zoccali, C., Mallamaci, F., Tripepi, G. L., Benedetto, F. A., Cutrupi, S., Parlongo, S., Malatino, L., Bonanno, G., Seminara, G., Rapisarda, F., et al. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v131134 · Cited by 756

Plasma Concentrations and Genetic Variation of Matrix Metalloproteinase 9 and Prognosis of Patients With Cardiovascular Disease

Blankenberg, S., Rupprecht, H. J., Poirier, O., Bickel, C., Smieja, M., Hafner, G., Meyer, J., Cambien, F., & Tiret, L. (2003) · Circulation · doi:10.1161/01.cir.0000058700.41738.12 · Cited by 755

Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: Implications for CD40–CD40 ligand signaling in atherosclerosis

Mach, F., Schönbeck, U., Sukhova, G. K., Bourcier, T., Bonnefoy, J., Pober, J. S., & Libby, P. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.5.1931 · Cited by 730

Angiogenesis Inhibitors Endostatin or TNP-470 Reduce Intimal Neovascularization and Plaque Growth in Apolipoprotein E–Deficient Mice

Moulton, K. S., Heller, E., Konerding, M. A., Flynn, E., Palinski, W., & Folkman, J. (1999) · Circulation · doi:10.1161/01.cir.99.13.1726 · Cited by 688

An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium.

Li, H., Cybulsky, M. I., Gimbrone, M. A., & Libby, P. (1993) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.13.2.197 · Cited by 686

Evidence for Increased Collagenolysis by Interstitial Collagenases-1 and -3 in Vulnerable Human Atheromatous Plaques

Sukhova, G. K., Schönbeck, U., Aïkawa, E., Schöen, F. J., Poole, A. R., Billinghurst, R. C., & Libby, P. (1999) · Circulation · doi:10.1161/01.cir.99.19.2503 · Cited by 660

Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis

Moulton, K. S., Vakili, K., Zurakowski, D., Soliman, M., Butterfield, C., Sylvin, E., Lo, K.-M., Gillies, S., Javaherian, K., & Folkman, J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0730843100 · Cited by 652

C-Reactive Protein Increases Plasminogen Activator Inhibitor-1 Expression and Activity in Human Aortic Endothelial Cells

Devaraj, S., Xu, D. Y., & Jialal, I. (2003) · Circulation · doi:10.1161/01.cir.0000052617.91920.fd · Cited by 641

Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells.

Amento, E. P., Ehsani, N., Palmer, H., & Libby, P. (1991) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.11.5.1223 · Cited by 609

Consequences of cellular cholesterol accumulation: basic concepts and physiological implications

Tabas, I. A. (2002) · Journal of Clinical Investigation · doi:10.1172/jci16452 · Cited by 608

Inflammation and Thrombosis

Libby, P., & Simon, D. I. (2001) · Circulation · doi:10.1161/01.cir.103.13.1718 · Cited by 605

High Plasminogen Activator Inhibitor and Tissue Plasminogen Activator Levels in Plasma Precede a First Acute Myocardial Infarction in Both Men and Women: Evidence for the Fibrinolytic System as an Independent Primary Risk Factor

Thögersen, A. M., Jansson, J.-H., Boman, K., Nilsson, T. K., Weinehall, L., Huhtasaari, F., & Hallmans, G. (1998) · Circulation · doi:10.1161/01.cir.98.21.2241 · Cited by 602

Inflammation and atherosclerosis: role of C-Reactive protein in risk assessment

Libby, P., & Ridker, P. M. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.02.006 · Cited by 601

Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes

Kai, H., Ikeda, H., Yasukawa, H., Kai, M., Seki, Y., Kuwahara, F., Ueno, T., Sugi, K., & Imaizumi, T. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00250-2 · Cited by 591

Stabilization of atherosclerotic plaques: New mechanisms and clinical targets

Libby, P., & Aikawa, M. (2002) · Nature Medicine · doi:10.1038/nm1102-1257 · Cited by 581

Interleukin-18 Is a Strong Predictor of Cardiovascular Death in Stable and Unstable Angina

Blankenberg, S., Tiret, L., Bickel, C., Peetz, D., Cambien, F., Meyer, J., & Rupprecht, H. J. (2002) · Circulation · doi:10.1161/01.cir.0000020546.30940.92 · Cited by 566

Inflammatory Cytokines Stimulated C-Reactive Protein Production by Human Coronary Artery Smooth Muscle Cells

Calabrò, P., Willerson, J. T., & Yeh, E. T. H. (2003) · Circulation · doi:10.1161/01.cir.0000096055.62724.c5 · Cited by 566

Consequences of cellular cholesterol accumulation: basic concepts and physiological implications

Tabas, I. A. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0216452 · Cited by 553

Expression of Interleukin (IL)-18 and Functional IL-18 Receptor on Human Vascular Endothelial Cells, Smooth Muscle Cells, and Macrophages

Gerdes, N., Sukhova, G. K., Libby, P., Reynolds, R. S., Young, J. L., & Schönbeck, U. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011022 · Cited by 509

PAI‐1 and atherothrombosis

Vaughan, D. E. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01420.x · Cited by 508

Matrix Metalloproteinase-9 (MMP-9), MMP-2, and Serum Elastase Activity Are Associated With Systolic Hypertension and Arterial Stiffness

Yasmin, Y., Wallace, S. M. L., McEniery, C. M., Dakham, Z., Pusalkar, P., Maki-Petaja, K. M., Ashby, M. J., Cockcroft, J. R., & Wilkinson, I. B. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000151373.33830.41 · Cited by 502

Activation of Monocyte/Macrophage Functions Related to Acute Atheroma Complication by Ligation of CD40

Mach, F., Schönbeck, U., Bonnefoy, J., Pober, J. S., & Libby, P. (1997) · Circulation · doi:10.1161/01.cir.96.2.396 · Cited by 493

Macrophage expression of active MMP-9 induces acute plaque disruption in apoE-deficient mice

Gough, P. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25074 · Cited by 470

Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells

Mach, F., Sauty, A., Iarossi, A. S., Sukhova, G. K., Neote, K. S., Libby, P., & Luster, A. D. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6993 · Cited by 466

Soluble CD40L and Cardiovascular Risk in Women

Schönbeck, U., Varo, N., Libby, P., Buring, J. E., & Ridker, P. M. (2001) · Circulation · doi:10.1161/hc4401.099447 · Cited by 458

Adiponectin: a key adipocytokine in metabolic syndrome

Okamoto, Y., Kihara, S., Funahashi, T., Matsuzawa, Y., & Libby, P. (2006) · Clinical Science · doi:10.1042/cs20050182 · Cited by 445

C-Reactive Protein Modulates Risk Prediction Based on the Framingham Score

Köenig, W., Löwel, H., Baumert, J. J., & Meisinger, C. (2004) · Circulation · doi:10.1161/01.cir.0000120707.98922.e3 · Cited by 440

Therapy Insight: adipocytokines in metabolic syndrome and related cardiovascular disease

Matsuzawa, Y. (2006) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio0380 · Cited by 434

Rosuvastatin in the Primary Prevention of Cardiovascular Disease Among Patients With Low Levels of Low-Density Lipoprotein Cholesterol and Elevated High-Sensitivity C-Reactive Protein

Ridker, P. M. (2003) · Circulation · doi:10.1161/01.cir.0000100688.17280.e6 · Cited by 424

The response‐to‐retention hypothesis of atherogenesis reinforced

Williams, K. J., & Tabas, I. (1998) · Current Opinion in Lipidology · doi:10.1097/00041433-199810000-00012 · Cited by 395

Adipose Tissue and Atherosclerosis

Fantuzzi, G., & Mazzone, T. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.106.131755 · Cited by 383

PAI-1, Obesity, Insulin Resistance and Risk of Cardiovascular Events

Juhan-Vague, I., & Alessi, M. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1657607 · Cited by 379

Macrophage colony-stimulating factor gene expression in vascular cells and in experimental and human atherosclerosis.

Clinton, S. K., Underwood, R., Hayes, L., Sherman, M. L., Kufe, D. W., & Libby, P. (1992) · PubMed Central · Cited by 378

Novel Inflammatory Markers of Coronary Risk

Libby, P., & Ridker, P. M. (1999) · Circulation · doi:10.1161/01.cir.100.11.1148 · Cited by 375

Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice

Schönbeck, U., Sukhova, G. K., Shimizu, K., Mach, F., & Libby, P. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.13.7458 · Cited by 358

Low-grade chronic inflammation in regions of the normal mouse arterial intima predisposed to atherosclerosis

Jongstra‐Bilen, J., Haidari, M., Zhu, S.-N., Chen, M., Guha, D., & Cybulsky, M. I. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060245 · Cited by 338

Lipids, risk factors and ischaemic heart disease

Castelli, W. P. (1996) · Atherosclerosis · doi:10.1016/0021-9150(96)05851-0 · Cited by 337

Platelet Expression Profiling and Clinical Validation of Myeloid-Related Protein-14 as a Novel Determinant of Cardiovascular Events

Healy, A. M., Pickard, M. D., Pradhan, A. D., Wang, Y., Chen, Z., Croce, K., Sakuma, M., Shi, C., Zago, A. C., Garasic, J. M., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.607333 · Cited by 336

Regulation of Matrix Metalloproteinase Expression in Human Vascular Smooth Muscle Cells by T Lymphocytes

Schönbeck, U., Mach, F., Sukhova, G. K., Murphy, C., Bonnefoy, J., Fabunmi, R. P., & Libby, P. (1997) · Circulation Research · doi:10.1161/01.res.81.3.448 · Cited by 334

C-Reactive Protein and Other Emerging Blood Biomarkers to Optimize Risk Stratification of Vulnerable Patients

Tsimikas, S., Willerson, J. T., & Ridker, P. M. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.10.066 · Cited by 332

Interleukin-18 and the Risk of Coronary Heart Disease in European Men

Blankenberg, S., Luc, G., Ducimetière, P., Arveiler, D., Ferrières, J., Amouyel, P., Evans, A., Cambien, F., & Tiret, L. (2003) · Circulation · doi:10.1161/01.cir.0000099509.76044.a2 · Cited by 332

Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease

Lara‐Castro, C., Fu, Y., Chung, B. H., & Garvey, W. T. (2007) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32814a645f · Cited by 320

Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasma plasminogen activator inhibitor-1 activity.

Dawson, S. J., Hamsten, A., Wiman, B., HENNEY, A. M., & Humphries, S. E. (1991) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.11.1.183 · Cited by 317

Apolipoprotein CIII Induces Expression of Vascular Cell Adhesion Molecule-1 in Vascular Endothelial Cells and Increases Adhesion of Monocytic Cells

Kawakami, A., Aikawa, M., Alcaide, P., Luscinskas, F. W., Libby, P., & Sacks, F. M. (2006) · Circulation · doi:10.1161/circulationaha.106.622514 · Cited by 305

Pre-existing coronary stenoses in patients with first myocardial infarction are not necessarily severe

Hackett, D., DAVIES, G., & Maseri, A. (1988) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a062449 · Cited by 289

Intertwining of thrombosis and inflammation in atherosclerosis

Croce, K., & Libby, P. (2007) · Current Opinion in Hematology · doi:10.1097/00062752-200701000-00011 · Cited by 285

Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndrome

Inokubo, Y., Hanada, H., Ishizaka, H., Fukushi, T., Kamada, T., & Okumura, K. (2001) · American Heart Journal · doi:10.1067/mhj.2001.112238 · Cited by 283

Effect of Activation and Inhibition of the Renin-Angiotensin System on Plasma PAI-1

Brown, N. J., Ağırbaşlı, M. A., Williams, G. H., Litchfield, W. R., & Vaughan, D. E. (1998) · Hypertension · doi:10.1161/01.hyp.32.6.965 · Cited by 269

Effects of Ramipril on Plasma Fibrinolytic Balance in Patients With Acute Anterior Myocardial Infarction

Vaughan, D. E., Rouleau, J. L., Ridker, P. M., Arnold, J. M. O., Menapace, F. J., & Pfeffer, M. A. (1997) · Circulation · doi:10.1161/01.cir.96.2.442 · Cited by 264

Matrix Metalloproteinase-9 Overexpression Enhances Vascular Smooth Muscle Cell Migration and Alters Remodeling in the Injured Rat Carotid Artery

Mason, D. P., Kenagy, R. D., Hasenstab, D., Bowen‐Pope, D. F., Seifert, R. A., Coats, S. A., Hawkins, S. M., & Clowes, A. W. (1999) · Circulation Research · doi:10.1161/01.res.85.12.1179 · Cited by 263

Hypoadiponectinemia as a Predictor for the Development of Hypertension

Chow, W.-S., Cheung, B. M. Y., Tso, A. W. K., Xu, A., Wat, N. M. S., Fong, C. H.-Y., Ong, L. H. Y., Tam, S., Tan, K. C. B., Janus, E. D., et al. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.086835 · Cited by 262

Multiple Abnormalities in Glucose and Energy Metabolism and Coordinated Changes in Levels of Adiponectin, Cytokines, and Adhesion Molecules in Subjects With Metabolic Syndrome

Salmenniemi, U., Ruotsalainen, E., Pihlajamäki, J., Vauhkonen, I., Kainulainen, S., Punnonen, K. R. A., Vanninen, E. J., & Laakso, M. (2004) · Circulation · doi:10.1161/01.cir.0000150391.38660.9b · Cited by 260

T Cells in Atherogenesis

Robertson, A.-K. L., & Hansson, G. K. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000245830.29764.84 · Cited by 259

Renal Pathology in Fabry Disease

Alroy, J., Sabnis, S. G., & Kopp, J. B. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000016684.07368.75 · Cited by 244

Elevated Interleukin-18 Levels Are Associated With the Metabolic Syndrome Independent of Obesity and Insulin Resistance

Hung, J., McQuillan, B., Chapman, C., Thompson, P. L., & Beilby, J. P. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000163843.70369.12 · Cited by 240

Association of Adiponectin with Coronary Heart Disease and Mortality: The Rancho Bernardo Study

Laughlin, G. A., Barrett-Connor, E. L., May, S. J., & Langenberg, C. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwk001 · Cited by 220

Elevated Levels of Interleukin-18 Predict the Development of Type 2 Diabetes

Thorand, B., Kolb, H., Baumert, J. J., Köenig, W., Chambless, L. E., Meisinger, C., Illig, T., Martin, S., & Herder, C. (2005) · Diabetes · doi:10.2337/diabetes.54.10.2932 · Cited by 216

Thematic review series: The Pathogenesis of Atherosclerosis. An interpretive history of the cholesterol controversy, part V: The discovery of the statins and the end of the controversy

Steinberg, D. H. (2006) · Journal of Lipid Research · doi:10.1194/jlr.r600009-jlr200 · Cited by 205

Inflammation and Atherothrombosis

Libby, P., & Ridker, P. M. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.08.011 · Cited by 204

Inducible expression of vascular cell adhesion molecule-1 by vascular smooth muscle cells in vitro and within rabbit atheroma.

Li, H., Cybulsky, M. I., Gimbrone, M. A., & Libby, P. (1993) · PubMed Central · Cited by 203

Thematic review series: The Pathogenesis of Atherosclerosis. An interpretive history of the cholesterol controversy: part I

Steinberg, D. H. (2004) · Journal of Lipid Research · doi:10.1194/jlr.r400003-jlr200 · Cited by 202

Oxidized low density lipoprotein and innate immune receptors

Miller, Y. I., Chang, M.-K., Binder, C. J., Shaw, P. X., & Witztum, J. L. (2003) · Current Opinion in Lipidology · doi:10.1097/00041433-200310000-00004 · Cited by 200

Thematic Review Series: The Immune System and Atherogenesis. Cytokines affecting endothelial and smooth muscle cells in vascular disease

Raines, E. W., & Ferri, N. (2005) · Journal of Lipid Research · doi:10.1194/jlr.r500004-jlr200 · Cited by 186

Thematic review series: The Pathogenesis of Atherosclerosis. An interpretive history of the cholesterol controversy: part II:the early evidence linking hypercholesterolemia to coronary disease in humans

Steinberg, D. H. (2004) · Journal of Lipid Research · doi:10.1194/jlr.r400012-jlr200 · Cited by 185

Cholesterol and atherosclerosis

Libby, P. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(00)00161-x · Cited by 183

Adiponectin, risk of coronary heart disease and correlations with cardiovascular risk markers

Rothenbacher, D., Brenner, H., März, W., & Köenig, W. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi340 · Cited by 175

Effect of Atorvastatin on Risk of Recurrent Cardiovascular Events After an Acute Coronary Syndrome Associated With High Soluble CD40 Ligand in the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study

Kinlay, S., Schwartz, G. G., OLSSON, A. G., Rifai, N., Sasiela, W. J., Szarek, M. J., Ganz, P., & Libby, P. (2004) · Circulation · doi:10.1161/01.cir.0000136588.62638.5e · Cited by 171

Age-Dependent Spontaneous Coronary Arterial Thrombosis in Transgenic Mice That Express a Stable Form of Human Plasminogen Activator Inhibitor-1

Eren, M., Painter, C., Atkinson, J. B., Declerck, P. J., & Vaughan, D. E. (2002) · Circulation · doi:10.1161/01.cir.0000023186.60090.fb · Cited by 170

Circulating Adiponectin Levels and Mortality in Elderly Men With and Without Cardiovascular Disease and Heart Failure

Wannamethee, S. G. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.14.1510 · Cited by 170

Serum Concentrations of Adiponectin and Risk of Type 2 Diabetes Mellitus and Coronary Heart Disease in Apparently Healthy Middle-Aged Men

Koenig, W., Khuseyinova, N., Baumert, J., Meisinger, C., & Löwel, H. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.06.053 · Cited by 166

Plasma concentration of soluble vascular cell adhesion molecule-1 and subsequent cardiovascular risk

de Lemos, J. A., Hennekens, C. H., & Ridker, P. M. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00742-7 · Cited by 163

CD40 Ligation Induces Tissue Factor Expression in Human Vascular Smooth Muscle Cells

Schönbeck, U., Mach, F., Sukhova, G. K., Herman, M., Graber, P., Kehry, M. R., & Libby, P. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64699-8 · Cited by 160

Local Generation of C-Reactive Protein in Diseased Coronary Artery Venous Bypass Grafts and Normal Vascular Tissue

Jabs, W. J., Theissing, E., Nitschke, M., Bechtel, M. F., Duchrow, M., Mohamed, S. A., Jahrbeck, B., Sievers, H., Steinhoff, J., & Bartels, C. (2003) · Circulation · doi:10.1161/01.cir.0000092184.43176.91 · Cited by 157

Plasma Adiponectin Levels Are Associated With Coronary Lesion Complexity in Men With Coronary Artery Disease

Otsuka, F., Sugiyama, S., Kojima, S., Maruyoshi, H., Funahashi, T., Matsui, K., Sakamoto, T., Yoshimura, M., Kimura, K., Umemura, S., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.05.054 · Cited by 156

A prospective study of fibrinogen and risk of myocardial infarction in the physicians’ health study

Ma, J., Hennekens, C. H., Ridker, P. M., & Stampfer, M. J. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00007-8 · Cited by 155

Expression of Stromelysin-3 in Atherosclerotic Lesions: Regulation via CD40–CD40 Ligand Signaling In Vitro and In Vivo

Schönbeck, U., Mach, F., Sukhova, G. K., Atkinson, E., Levesque, E. B., Herman, M. P., Graber, P., Basset, P., & Libby, P. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.5.843 · Cited by 154

Circulating Matrix Metalloproteinases and Their Inhibitors in Premature Coronary Atherosclerosis

Noji, Y., Kajinami, K., Kawashiri, M., Todo, Y., Horita, T., Nohara, A., Higashikata, T., Inazu, A., Koizumi, J., Takegoshi, T., et al. (2001) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2001.060 · Cited by 151

Promoter (4G/5G) Plasminogen Activator Inhibitor-1 Genotype and Plasminogen Activator Inhibitor-1 Levels in Blacks, Hispanics, and Non-Hispanic Whites

Festa, A., D’Agostino, R., Rich, S. S., Jenny, N. S., Tracy, R. P., & Haffner, S. M. (2003) · Circulation · doi:10.1161/01.cir.0000066908.82782.3a · Cited by 148

Leptin Induces C-Reactive Protein Expression in Vascular Endothelial Cells

Singh, P., Hoffmann, M., Wolk, R. A., Shamsuzzaman, A., & Somers, V. K. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.148353 · Cited by 140

Thematic review series: The Pathogenesis of Atherosclerosis. An interpretive history of the cholesterol controversy, part III: mechanistically defining the role of hyperlipidemia

Steinberg, D. H. (2005) · Journal of Lipid Research · doi:10.1194/jlr.r500010-jlr200 · Cited by 136

The proatherogenic cytokine interleukin-18 is secreted by human adipocytes

Skurk, T., Kolb, H., Müller-Scholze, S., Röhrig, K., Hauner, H., & Herder, C. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01897 · Cited by 135

Induction of Tissue Factor Expression in Human Endothelial Cells by CD40 Ligand Is Mediated via Activator Protein 1, Nuclear Factor κB, and Egr-1

Bavendiek, U., Libby, P., Kilbride, M., Reynolds, R. S., Mackman, N., & Schönbeck, U. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204003200 · Cited by 134

Effects of Rosiglitazone on Lipids, Adipokines, and Inflammatory Markers in Nondiabetic Patients With Low High-Density Lipoprotein Cholesterol and Metabolic Syndrome

Samaha, F. F., Szapary, P. O., Iqbal, N., Williams, M. M., Bloedon, L. T., Kochar, A., Wolfe, M. L., & Rader, D. J. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000200136.56716.30 · Cited by 129

Effects of Peroxisome Proliferator-Activated Receptor Ligands, Bezafibrate and Fenofibrate, on Adiponectin Level

Hiuge, A., Tenenbaum, A., Maeda, N., Benderly, M., Kumada, M., Fisman, E. Z., Tanné, D., Matas, Z., Hibuse, T., Fujita, K., et al. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000256469.06782.d5 · Cited by 122

Adhesion of Monocytes to Vascular Cell Adhesion Molecule-1–Transduced Human Endothelial Cells

Gerszten, R. E., Lim, Y.-C., Ding, H. T., Snapp, K. R., Kansas, G. S., Dichek, D. A., Cabañas, C., Sánchez‐Madrid, F., Gimbrone, M. A., Rosenzweig, A., et al. (1998) · Circulation Research · doi:10.1161/01.res.82.8.871 · Cited by 113

Interleukin-18, the Metabolic Syndrome, and Subclinical Atherosclerosis

Zirlik, A., Abdullah, S. M., Gerdes, N., MacFarlane, L. A., Schönbeck, U., Khera, A., McGuire, D. K., Vega, G. L., Grundy, S. M., Libby, P., et al. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.149484 · Cited by 113

Sequestration of aggregated low-density lipoproteins by macrophages

Kruth, H. S. (2002) · Current Opinion in Lipidology · doi:10.1097/00041433-200210000-00003 · Cited by 111

Plasma Matrix Metalloproteinase-9, Tissue Inhibitor of Metalloproteinase-2, and CD40 Ligand Levels in Patients With Stable Coronary Artery Disease

Tayebjee, M. H., Lip, G. Y. H., Tan, K. T., Patel, J. V., Hughes, E. A., & MacFadyen, R. J. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.03.072 · Cited by 103

Plasma Adiponectin Levels and Sonographic Phenotypes of Subclinical Carotid Artery Atherosclerosis

Iglseder, B., Mackēvičs, V., Stadlmayer, A., Tasch, G., Ladurner, G., & Paulweber, B. (2005) · Stroke · doi:10.1161/01.str.0000190834.00284.fd · Cited by 97

Associations Between Soluble CD40 Ligand, Atherosclerosis Risk Factors, and Subclinical Atherosclerosis

de Lemos, J. A., Zirlik, A., Schönbeck, U., Varo, N., Murphy, S. A., Khera, A., McGuire, D. K., Stanek, G., Lo, H. S., Nuzzo, R., et al. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000182904.08513.60 · Cited by 94

Interactions of monocytic cells with human endothelial cells stimulate monocytic metalloproteinase production.

Amorino, G. P., & Hoover, R. L. (1998) · PubMed · Cited by 88

Association of adiponectin and resistin with cardiovascular events in Korean patients with type 2 diabetes: The Korean atherosclerosis study (KAS)

Lim, S. K., Koo, B. K., Cho, S. W., Kihara, S., Funahashi, T., Cho, Y. M., Kim, S. Y., Lee, H. K., Shimomura, I., & Park, K. S. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.11.017 · Cited by 85

Inflammatory Biomarkers in Stable Atherosclerosis

Kinlay, S., & Egido, J. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.09.014 · Cited by 84

Soluble CD40 Ligand Levels Indicate Lipid Accumulation in Carotid Atheroma

Blake, G. J., Ostfeld, R. J., Yucel, E. K., Varo, N., Schönbeck, U., Blake, M. A., Gerhard, M. D., Ridker, P. M., Libby, P., & Lee, R. T. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000050143.22910.62 · Cited by 84

Hormone Replacement Therapy and Risk of Cardiovascular Disease

Kuller, L. H. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000046033.32478.6d · Cited by 83

Additive Value of Immunoassay-Measured Fibrinogen and High-Sensitivity C-Reactive Protein Levels for Predicting Incident Cardiovascular Events

Mora, S., Rifai, N., Buring, J. E., & Ridker, P. M. (2006) · Circulation · doi:10.1161/circulationaha.106.634089 · Cited by 82

Elevated Matrix Metalloproteinase-9 Associated With Stroke or Cardiovascular Death in Patients With Carotid Stenosis

Eldrup, N., Grønholdt, M.-L. M., Sillesen, H. H., & Nordestgaard, B. G. (2006) · Circulation · doi:10.1161/circulationaha.105.593483 · Cited by 81

Effect of simvastatin and/or pioglitazone on insulin resistance, insulin secretion, adiponectin, and proinsulin levels in nondiabetic patients at cardiovascular risk—the PIOSTAT Study

Forst, T. M., Pfützner, A., Lübben, G., Weber, M. M., Marx, N., Karagiannis, E., Koehler, C., Baurecht, W., Hohberg, C., & Hanefeld, M. (2007) · Metabolism · doi:10.1016/j.metabol.2006.11.007 · Cited by 67

Adiponectin and its correlates of cardiovascular risk in young adults: the Bogalusa Heart Study

Patel, D. A., Srinivasan, S. R., Xu, J.-H., Chen, W., & Berenson, G. S. (2006) · Metabolism · doi:10.1016/j.metabol.2006.06.028 · Cited by 62

Soluble CD40L and Cardiovascular Risk in Asymptomatic Low-Grade Carotid Stenosis

Novo, S., Basili, S., Tantillo, R., Falco, A., Davì, V., Novo, G., Corrado, E., & Davı̀, G. (2005) · Stroke · doi:10.1161/01.str.0000154878.58398.14 · Cited by 62

Influence of pre-analytical and analytical factors on soluble CD40L measurements

Varo, N., Nuzzo, R., Natal, C., Libby, P., & Schönbeck, U. (2006) · Clinical Science · doi:10.1042/cs20060047 · Cited by 59

Overexpression of matrix metalloproteinase-9 promotes intravascular thrombus formation in porcine coronary arteries in vivo

Morishige, K. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00710-1 · Cited by 59

Comparative Effects of Estrogen and Angiotensin-Converting Enzyme Inhibition on Plasminogen Activator Inhibitor-1 in Healthy Postmenopausal Women

Brown, N. J., Abbas, A., Byrne, D. W., Schoenhard, J. A., & Vaughan, D. E. (2002) · Circulation · doi:10.1161/hc0302.102570 · Cited by 58

Adhesion of Memory Lymphocytes to Vascular Cell Adhesion Molecule-1–Transduced Human Vascular Endothelial Cells Under Simulated Physiological Flow Conditions In Vitro

Gerszten, R. E., Luscinskas, F. W., Ding, H. T., Dichek, D. A., Stoolman, L. M., Gimbrone, M. A., & Rosenzweig, A. (1996) · Circulation Research · doi:10.1161/01.res.79.6.1205 · Cited by 58

Lower plasma adiponectin is a marker of increased intima-media thickness associated with type 2 diabetes mellitus and with male gender

Dullaart, R. P. F., de Vries, R., van Tol, A., & Sluiter, W. J. (2007) · European Journal of Endocrinology · doi:10.1530/eje-06-0681 · Cited by 57

Thematic review series: The Pathogenesis of Atherosclerosis. An interpretive history of the cholesterol controversy, part IV: The 1984 Coronary Primary Prevention Trial ends it—almost

Steinberg, D. H. (2005) · Journal of Lipid Research · doi:10.1194/jlr.r500014-jlr200 · Cited by 56

Influence of Sample Type and Storage Conditions on Soluble CD40 Ligand Assessment

Weber, M. W., Rabenau, B., Stanisch, M., Elsaesser, A., Mitrovic, V., Heeschen, C., & Hamm, C. W. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2005.062083 · Cited by 49

The Inflammatory Hypothesis

Blankenberg, S., & Yusuf, S. (2006) · Circulation · doi:10.1161/circulationaha.106.652081 · Cited by 33

Interleukin-18 levels are not associated with subclinical carotid atherosclerosis in a community population

Chapman, C., McQuillan, B., Beilby, J. P., Thompson, P. L., & Hung, J. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.12.026 · Cited by 29

Adiponectin levels are associated with coronary artery disease across Caucasian and African-American ethnicity

Lu, G., Chiem, A. T., Anuurad, E., Havel, P. J., Pearson, T. A., Ormsby, B., & Berglund, L. (2007) · Translational research · doi:10.1016/j.trsl.2006.12.008 · Cited by 26

The presence of metabolic syndrome is independently associated with elevated serum CD40 ligand and disease severity in patients with symptomatic coronary artery disease

Lee, W.-L., Lee, W., Chen, Y., Liu, T.-J., Liang, K., Ting, C.-T., & Sheu, W. H. (2006) · Metabolism · doi:10.1016/j.metabol.2006.03.013 · Cited by 23

Soluble CD154 Is a Unique Predictor of Nonfatal and Fatal Atherothrombotic Events in Patients Who Have End-Stage Renal Disease and Are on Hemodialysis

Hocher, B., Liefeldt, L., Quaschning, T., Kalk, P., Ziebig, R., Godes, M., Relle, K., Asmus, G., & Stasch, J.-P. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006070684 · Cited by 19

Editorial board

(2006) · The American Journal of Cardiology · doi:10.1016/s0002-9149(06)01415-9 · Cited by 10

Inflammatory responses and inflammation-associated diseases in organs

Chen, L., Deng, H., Cui, H., Fang, J. S., Zuo, Z., Deng, J., Li, Y., Wang, X., & Zhao, L. (2017) · Oncotarget · doi:10.18632/oncotarget.23208 · Cited by 5,541

Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases

Aggarwal, B. B., & Harikumar, K. B. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.06.010 · Cited by 2,139

Relation Between Red Blood Cell Distribution Width and Inflammatory Biomarkers in a Large Cohort of Unselected Outpatients

Lippi, G., Targher, G., Montagnana, M., Salvagno, G. L., Zoppini, G., & Guidi, G. C. (2009) · Archives of Pathology & Laboratory Medicine · doi:10.5858/133.4.628 · Cited by 1,095

Milk-derived bioactive peptides: From science to applications

Korhonen, H. J. T. (2009) · Journal of Functional Foods · doi:10.1016/j.jff.2009.01.007 · Cited by 729

Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases

Kell, D. B. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-2 · Cited by 554

Inflammation in Atherosclerosis: From Vascular Biology to Biomarker Discovery and Risk

Packard, R. R. S., & Libby, P. (2007)

Inflammatory Biomarkers Predicting Events in Atherosclerosis

Stefanadi, E., Tousoulis, D., Παπαγεωργίου, Ν., Briasoulis, Α., & Stefanadis, C. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710791111288 · Cited by 36

Open Access Expanded Network of Inflammatory Markers of Atherogenesis: Where Are We Now?

Abbasi, S. H., & Boroum, M. A. (2013)

Inflammation and Atherosclerosis

Steffens, S., & Mach, F. (2004) · Herz · doi:10.1007/s00059-004-2634-9 · Cited by 77

THE ROLE OF INFLAMMATION IN THE PATHOGENESIS OF ATHEROSCLEROSIS

Kazakova, M., Vysotskaya, K., & Mitkovskaya, N. (2022) · Emergency Cardiology and Cardiovascular Risks · doi:10.51922/2616-633x.2022.6.2.1707 · Cited by 3